Ocular Hypertension and Primary Open-Angle Glaucoma
The live program has concluded.
If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.
Overview
This continuing medical education (CME) activity captures content from a roundtable discussion held in May 2016. This certified CME activity is designed for glaucoma specialists and general ophthalmologists involved in the management of glaucoma and associated disorders.Provided by Evolve Medical Education LLC and distributed with Glaucoma Today. Supported through an educational grant by Bausch & Lomb Incorporated. Learning Objectives
Upon completion of this activity, the participant should be able to:
- Discuss the limitations of current treatment regimens from both mechanism of action and patient compliance.
- Explain how novel therapeutics differ in their methods of action from commercially available topical medications
- Evaluate the safety and efficacy of different treatment modalities for ocular hypertension and primary open-angle glaucoma
- Assess the latest clinical trial data pertaining to new therapies
- Discuss future developments and direction of therapeutics for managing glaucoma
Faculty and Disclosures
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.L. Jay Katz, MD, moderator Wills Eye Hospital Philadelphia, Pennsylvania
Jason Bacharach, MD North Bay Eye Associates Sonoma, California
Yvonne M. Buys, MD Toronto Western Hospital Toronto, Canada
Louis B. Cantor, MD Indiana University School of Medicine Indianapolis, Indiana
It is the policy of Evolve Medical Education LLC that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve Medical Education LLC has full policies in place that will identify and resolve all conflict of interests prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
L. Jay Katz, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Aerie Pharmaceuticals; Aerpio Therapeutics; Alcon; Allergan; Glaukos Corporation; Inotek Pharmaceuticals; and Ocular Therapeutix. Grant/Research Support: Aerie Pharmaceuticals; Alcon; Allergan; Bausch & Lomb Incorporated; Glaukos Corporation; InnFocus; Inotek Pharmaceuticals; and Mati Therapeutics. Stock/Shareholder: Aerie Pharmaceuticals; Glaukos Corporation; and Mati Therapeutics.
Jason Bacharach, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Aerie Pharmaceuticals; Alcon; Allergan; Glaukos Corporation; and Sun Pharmaceutical Industries Ltd. Grant/Research Support: Aerie Pharmaceuticals; Alcon; Allergan; Bausch & Lomb Incorporated; and Glaukos Corporation. Stock/Shareholder: Glaukos Corporation.
Yvonne M. Buys, MD, has had no financial agreement or affiliations during the past year.
Louis B. Cantor, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board/Speaker’s Bureau: Abbott Medical Optics; Allergan; Glaukos Corporation; Inotek Pharmaceuticals; Mati Therapeutics; and Ocular Therapeutix. Grant/Research Support: Alcon; Allergan; and Bausch & Lomb Incorporated.
Cheryl Cavanaugh, MS, director of operations, Evolve Medical Education LLC; Michelle Dalton, writer; and Melanie Lawler, PhD, reviewer, have no financial relationships with commercial interests.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education LLC, Glaucoma Today, or Bausch & Lomb Incorporated.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!